AFP BY TOPIC

Atrial Fibrillation

Editors' Choice of Best Available Content

PRINT
COMMENTS

ADD TO FAVORITES REMOVE FAVORITE

This page will be removed from your Favorites Links. Are you sure?

This collection features the best content from AFP, as identified by the AFP editors, on atrial fibrillation and related issues, including anticoagulation therapy, antiplatelet therapy, arrhythmias, and palpitations. New research may affect the interpretation and application of this material. Clinical judgment is advised. Note that AFP content published within the past 12 months is accessible to AAFP members and paid subscribers only.

Categories

Overview

Screening and Diagnosis

Treatment

Improving Practice

Patient Education, Self-Care

Other AFP Content

Other Resources from AAFP

Overview
01/15/2019	Fitness-Related Cardiac Arrhythmias [Editorials] new
09/01/2017	Newly Detected Atrial Fibrillation: AAFP Updates Guideline on Pharmacologic Management [Practice Guidelines]
09/01/2017	Differences Between the AAFP Atrial Fibrillation Guideline and the AHA/ACC/HRS Guideline [Editorials]
09/15/2016	Diagnosis and Treatment of Atrial Fibrillation
12/01/2011	Updated Guidelines on Management of Atrial Fibrillation from the ACCF/AHA/HRS [Practice Guidelines]
Screening and Diagnosis
12/15/2017	Palpitations: Evaluation in the Primary Care Setting
09/15/2012	Evaluation of Asymptomatic Atrial Fibrillation [FPIN's Clinical Inquiries]
Treatment
Acute
12/01/2005	Pharmacologic Cardioversion for Atrial Fibrillation and Flutter [Cochrane for Clinicians]
05/01/2004	Atrial Fibrillation (Acute) [Clinical Evidence Handbook]
Chronic
12/15/2018	Evaluating Benefits and Harms of Anticoagulation in Patients with Atrial Fibrillation [Point-of-Care Guides] new
07/01/2018	Bleeding with Anticoagulants: ACC Releases Expert Consensus Decision Pathway to Guide Management [Practice Guidelines]
04/15/2018	Edoxaban (Savaysa) for the Prevention of Thromboembolic Events [STEPS]
10/01/2017	Assessing Bleeding Risk in Patients Taking Anticoagulants [Point-of-Care Guides]
06/15/2017	Idarucizumab (Praxbind) for Dabigatran (Pradaxa) Anticoagulant Reversal [STEPS]
06/01/2017	Self-Monitoring and Self-Management of Oral Anticoagulation [Cochrane for Clinicians]
10/01/2016	Rivaroxaban vs. Warfarin for Anticoagulation in Patients with Atrial Fibrillation Undergoing Ablation and Cardioversion [Medicine by the Numbers]
04/15/2014	Apixaban (Eliquis) for Stroke Prevention in Atrial Fibrillation [STEPS]
05/15/2013	AHA/ASA Publish Advisory on Oral Antithrombotics for Stroke Prevention in Nonvalvular Artial Fibrillation [Practice Guidelines]
04/15/2013	Updated Guidelines on Outpatient Anticoagulation
10/15/2012	Rivaroxaban (Xarelto) for Prevention of Thromboembolic Events [STEPS]
10/15/2012	Chronic Atrial Fibrillation [Clinical Evidence Handbook]
03/15/2012	Rivaroxaban vs. Warfarin for Stroke Prevention in Patients with Nonvalvular Atrial Fibrillation [AFP Journal Club]
12/15/2011	Dabigatran (Pradaxa) for Prevention of Stroke in Atrial Fibrillation [STEPS]
11/15/2009	Catheter Ablation of Supraventricular Arrhythmias and Atrial Fibrilation
05/01/2008	Oral Anticoagulants vs. Antiplatelet Therapy [Cochrane for Clinicians]
02/15/2005	Evidence-Based Initiation of Warfarin (Coumadin) [Point-of-Care Guides]
09/01/2004	Which Patients with Atrial Fibrillation Do Not Need Anticoagulation Therapy with Warfarin? [FPIN's Clinical Inquiries]
Improving Practice
From FPM AAFP's Peer-Reviewed Practice Improvement Journal
05/01/2005	A Systematic Approach to Managing Warfarin Doses
05/01/2005	Outpatient Anticoagulation Flowsheet
02/01/2002	Improving Anticoagulation Management at the Point of Care
Patient Education, Self-Care
09/15/2016	Atrial Fibrillation
Other AFP Content
TIPS FROM OTHER JOURNALS
Other Resources from AAFP
(04/01/2017)	Pharmacologic Management of Newly Detected Atrial Fibrillation-Clinical Practice Guideline